OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission: results from the biodam cohort

A Sepriano; S Ramiro; R Landewé; D Van Der Heijde; S Ohrndorf; O Fitzgerald; M Backhaus; M Larché; J Homik; A Saraux; H Hammer; L Terslev; M Østergaard; G Burmester; B Combe; M Dougados; C Hitchon; G Boire; R Dadashova; J Paschke; E Hutchings; W Maksymowych

doi:10.1136/annrheumdis-2017-eular.1613

OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission: results from the biodam cohort

A Sepriano, S Ramiro, R Landewé, D Van Der Heijde, S Ohrndorf, O Fitzgerald, M Backhaus, M Larché, J Homik, A Saraux, H Hammer, L Terslev, M Østergaard, G Burmester, B Combe, M Dougados, C Hitchon, G Boire, R Dadashova, J PaschkeE Hutchings, W Maksymowych

Institut for Klinisk Medicin

Originalsprog	Engelsk
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	76
Udgave nummer	Suppl 2
Sider (fra-til)	131
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2017-eular.1613
Status	Udgivet - 2017

Adgang til dokumentet

10.1136/annrheumdis-2017-eular.1613

131.1.full.pdfForlagets udgivne version, 158 KB

Citationsformater

Sepriano, A., Ramiro, S., Landewé, R., Heijde, D. V. D., Ohrndorf, S., Fitzgerald, O., Backhaus, M., Larché, M., Homik, J., Saraux, A., Hammer, H., Terslev, L., Østergaard, M., Burmester, G., Combe, B., Dougados, M., Hitchon, C., Boire, G., Dadashova, R., ... Maksymowych, W. (2017). OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission: results from the biodam cohort. Annals of the Rheumatic Diseases, 76(Suppl 2), 131. https://doi.org/10.1136/annrheumdis-2017-eular.1613

Sepriano, A, Ramiro, S, Landewé, R, Heijde, DVD, Ohrndorf, S, Fitzgerald, O, Backhaus, M, Larché, M, Homik, J, Saraux, A, Hammer, H, Terslev, L, Østergaard, M, Burmester, G, Combe, B, Dougados, M, Hitchon, C, Boire, G, Dadashova, R, Paschke, J, Hutchings, E & Maksymowych, W 2017, 'OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission: results from the biodam cohort', Annals of the Rheumatic Diseases, bind 76, nr. Suppl 2, s. 131. https://doi.org/10.1136/annrheumdis-2017-eular.1613

@article{5e1f9711b2f24c1a91c603973aeeb35c,

title = "OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission: results from the biodam cohort",

author = "A Sepriano and S Ramiro and R Landew{\'e} and Heijde, {D Van Der} and S Ohrndorf and O Fitzgerald and M Backhaus and M Larch{\'e} and J Homik and A Saraux and H Hammer and L Terslev and M {\O}stergaard and G Burmester and B Combe and M Dougados and C Hitchon and G Boire and R Dadashova and J Paschke and E Hutchings and W Maksymowych",

year = "2017",

doi = "10.1136/annrheumdis-2017-eular.1613",

language = "English",

volume = "76",

pages = "131",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl 2",

}

TY - ABST

T1 - OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission

T2 - results from the biodam cohort

AU - Sepriano, A

AU - Ramiro, S

AU - Landewé, R

AU - Heijde, D Van Der

AU - Ohrndorf, S

AU - Fitzgerald, O

AU - Backhaus, M

AU - Larché, M

AU - Homik, J

AU - Saraux, A

AU - Hammer, H

AU - Terslev, L

AU - Østergaard, M

AU - Burmester, G

AU - Combe, B

AU - Dougados, M

AU - Hitchon, C

AU - Boire, G

AU - Dadashova, R

AU - Paschke, J

AU - Hutchings, E

AU - Maksymowych, W

PY - 2017

Y1 - 2017

U2 - 10.1136/annrheumdis-2017-eular.1613

DO - 10.1136/annrheumdis-2017-eular.1613

M3 - Conference abstract in journal

SN - 0003-4967

VL - 76

SP - 131

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 2

ER -